There was no difference in sCD163 levels according to subgroups based on initial presentation (asymptomatic, neurologic, hepatic, or mixed), but patients with cirrhosis at the time of diagnosis had higher sCD163 levels compared with patients without cirrhosis (3.0 (1.2–24.9) mg/L vs. 2.3 (0.9–8.0) mg/L, p < 0.001) (Fig. 1). The gene discussed is CD163; the disease is Cirrhosis.